The promise of miRNA replacement therapy for Hepatocellular carcinoma.
MicroRNA modulation therapy has shown great promise to treat hepatocellular carcinoma (HCC). the present review will discuss the prominent examples of tumor silencer miRNA in terms of their efficient delivery using vectors, nano-delivery systems their successful models either in vitro or in vivo and pre-clinical trials. Hepatocellular carcinoma is a devastating tumor which accounts for death mortality rate 94% globally, and about 780,000 new cases each year. Tumor suppressor miRNAs represent a class of noncoding RNAs, which exhibit decreased or inhibited expression in case of carcinogenesis. Therefore, replacement of these molecules leads to post transcriptional regulation of tens to hundreds of oncogenic targets and limiting the tumor. tumor suppressor miRNAs can act as novel therapeutics for HCC and more studies should be directed toward these promising therapeutics.